Texas Health and Human Services Commission sent this bulletin at 01/26/2022 03:26 PM CST / Este e-mail ha sido enviado por Texas Health and Human Services Commission el 01/26/2022 03:26 PM CST
This update includes changes approved at the July and November 2021 Drug Utilization Review Board meetings. The document consists of formulary and prior authorization information, notations for drugs requiring clinical prior authorization, and appendices for cough and cold products, iron oral agents, and prenatal vitamins.